Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Reg Anesth Pain Med. 2021 Jul 2;46(9):752–756. doi: 10.1136/rapm-2021-102501

Table 2.

Unadjusted means (SD) for secondary outcomes across the trial

RFA (n=30) Sham (n=30)
Secondary Outcome* Baseline DOS 2-week FU 6-week FU Baseline DOS 2-week FU 6-week FU
Pain with ambulation 6.0 (2.4) 5.2 (2.2) 3.8 (1.8) 2.7 (1.8) 5.8 (1.8) 5.4 (2.2) 3.6 (1.7) 1.9 (1.5)
PROMIS Physical Function 37.8 (6.1) 40.0 (6.0) 36.3 (4.3) 41.4 (3.4) 36.5 (4.9) 37.1 (4.3) 37.1 (6.1) 44.0 (8.3)
*

All comparisons for changes from baseline to each follow-up between groups were non-significant based on between-subject t-tests.

DOS, day of surgery; FU, follow-up; PROMIS, Patient Reported Outcome Measurement Information System; RFA, radiofrequency ablation.